FIELD: medicine.
SUBSTANCE: group of inventions relates to the combination of compound A (R)-4-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)-3-fluorobenzonitrile and a pasireotide somatostatin analogue, where the active substances are present in each case in free form, in the form of a complex or in the form of a pharmaceutically acceptable salt.
EFFECT: invention relates to a method for the treatment and use of a combination for the preparation of a medicament for the treatment of Cushing's syndrome or Cushing's disease.
7 cl, 3 tbl, 3 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF AGENT WITH MODIFYING PROPERTIES IN RELATION TO HORMONES OF ADRENAL GLANDS | 2011 |
|
RU2598708C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF ADRENAL GROWTHS | 2015 |
|
RU2583918C1 |
| METHOD OF INDIVIDUAL RECOVERY OF FUNCTIONAL ACTIVITY OF ADRENAL CORTEX IN PATIENTS WITH SOMATIC DISEASES WITH LONG HISTORY OF GLUCOCORTICOSTEROID THERAPY | 2010 |
|
RU2439563C1 |
| METHOD FOR DIAGNOSING OBLITERATED FORMS OF CONGENITAL SUPRARENAL GLAND CORTEX HYPERPLASIA | 2004 |
|
RU2261447C1 |
| CFR RECEPTOR ANTAGONISTS FOR TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA | 2015 |
|
RU2812318C2 |
| USING SOMATOSTATIN ANALOGUES IN MENINGIOMA | 2008 |
|
RU2523416C2 |
| CFR RECEPTOR ANTAGONISTS FOR TREATING CONGENITAL ADRENAL HYPERPLASIA | 2015 |
|
RU2718918C2 |
| DIAGNOSTIC TECHNIQUE FOR CLINICALLY LATENT HYPERCORTICOIDISM IN PATIENTS SUFFERING FROM STYPE 2 DIABETES MELLITUS OR OBESITY | 2012 |
|
RU2521387C1 |
| METHOD FOR DETERMINING PROBABILITY OF ACTH-ECTOPIC SYNDROME IN PATIENTS WITH ACTH-DEPENDENT ENDOGENOUS HYPERADRENOCORTICISM | 2023 |
|
RU2814146C1 |
| COMBINATION OF SOMATOSTATIN ANALOGUES WITH VARIED SELECTIVITY WITH REGARD TO HUMAN SOMATOSTATIN RECEPTORS SUBTYPES | 2007 |
|
RU2451520C2 |
